opioid use disorder

News

Indivior bags $111m contract from US for overdose therapy

Indivior has secured a $111 million supply contract from the US federal government for its intranasal therapy for treating opioid overdose, in a further boost to the UK co

News

FDA OKs test to spot patients at risk of opioid use disorder

A test that can be given to patients before they are prescribed a course of opioid analgesics to check whether they are at risk of becoming dependent on the drugs has been

News

OTC Narcan will arrive next week, at $45 per pack

Emergent BioSolutions has confirmed that its over-the-counter (OTC) version of overdose reversal agent Narcan will be available on the shelves of pharmacies, grocery store

News

Pear extends digital therapeutics partnership with Spero

Addiction treatment specialist Spero Health has expanded an agreement to use Pear Therapeutics’ prescription digital therapeutics (DTx) in its network of US clinics.

News

Indivior boosts addiction drug business with $145m Opiant de...

UK-based pharma Indivior has agreed a takeover deal with Opiant Pharma that consolidates its position in the addiction treatment category with a new intranasal therapy, due to be filed with

News

Telehealth cuts overdoses for opioid users, says study

Greater use of telehealth services forced by COVID-19 seems to have benefitted people with opioid use disorder (OUD), leading to longer times on treatment and reduced risk of overdose, acco

Indivior bags $111m contract from US for overdose therapy

FDA OKs test to spot patients at risk of opioid use disorder

OTC Narcan will arrive next week, at $45 per pack

Pear extends digital therapeutics partnership with Spero

Indivior boosts addiction drug business with $145m Opiant de...

Telehealth cuts overdoses for opioid users, says study

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

opioid use disorder

Editor's Picks